| Betashares S&P Australian Shares High Yield ETF (HYLD) BETASHARES S&P AUSTRALIAN SHARES HIGH YIELD ETF |
- |
$93 |
Final Distribution Announcement
|
30 Jan 2026 6:19PM |
$32.010 |
$33.630 |
risen by
5.06%
|
|
| Betashares Active Australian Hybrids Fund (Managed Fund) (HBRD) |
Financials |
$2,499 |
Final Distribution Announcement
|
30 Jan 2026 6:19PM |
$10.140 |
$10.070 |
fallen by
0.69%
|
|
| Betashares 2028 Fixed Term Corporate Bond Active ETF (28BB) |
Financials |
$6 |
Final Distribution Announcement
|
30 Jan 2026 6:19PM |
$24.970 |
$24.830 |
fallen by
0.56%
|
|
| Big River Industries Limited (BRI) ORDINARY FULLY PAID |
Materials |
$124 |
Change in substantial holding
|
30 Jan 2026 6:19PM |
$1.390 |
$1.320 |
fallen by
5.04%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$4 |
Appendix 4C and Quarterly Activities Report - December 2025
|
30 Jan 2026 6:18PM |
$0.092 |
$0.044 |
fallen by
52.17%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Non-dilutive $2 million funding from KDDF for oesophageal cancer treatment.
- Secured expanded global exclusive license for Photosoftâ„¢ technology.
- Collaboration with Protect Animal Health Inc. for companion animal cancer treatments.
- Raised $1.3 million through convertible notes.
- Secured a $400K R&D advance facility.
- Cash reserves of $138K at quarter end.
- Continued focus on human and animal health programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SiteMinder Limited (SDR) ORDINARY FULLY PAID |
Information Technology |
$1,059 |
Ceasing to be a substantial holder
|
30 Jan 2026 6:17PM |
$5.080 |
$3.740 |
fallen by
26.38%
|
|
| West African Resources Limited (WAF) ORDINARY FULLY PAID |
Materials |
$3,431 |
Becoming a substantial holder
|
30 Jan 2026 6:17PM |
$3.690 |
$3.000 |
fallen by
18.70%
|
|
| African Gold Limited (A1G) ORDINARY FULLY PAID |
Materials |
$592 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 6:16PM |
$0.820 |
$1.040 |
risen by
26.83%
|
|
A1G - Price-sensitive ASX Announcement
Full Release
Key Points
- Scheme of Arrangement with Montage Gold Corp agreed.
- Drilling at Blaffo Guetto returned high-grade intersections.
- Metallurgical test confirmed non-refractory ore suitable for conventional CIL processing.
- Option exercised to acquire an 80% interest in Kouroufaba Gold Ltd.
- Cash position strengthened through share sales and option exercises.
- Ongoing exploration at Didievi and Konahiri projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nagambie Resources Limited (NAG) ORDINARY FULLY PAID |
Materials |
$13 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 6:16PM |
$0.015 |
$0.010 |
fallen by
33.33%
|
|
NAG - Price-sensitive ASX Announcement
Full Release
Key Points
- Alkane Resources Ltd to earn up to 80% interest in Nagambie tenements.
- Joint venture with Alkane for Nagambie Mine's antimony-gold discovery.
- Alkane's $2.5 million share subscription in NAG shares.
- Nagambie's balance sheet improved by $4.0 million.
- Nagambie retains 100% of Whroo Mines and Wandean Projects.
- Cash balance of $717,000 at December 31, 2025.
- Secured loan facility of $3.0 million with PPT Nominees Pty Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Evion Group NL (EVG) ORDINARY FULLY PAID |
Materials |
$26 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 6:16PM |
$0.027 |
$0.036 |
risen by
33.33%
|
|
EVG - Price-sensitive ASX Announcement
Full Release
Key Points
- Evion Group NL, an ASX-listed company, reports on its quarterly activities and cash flow.
- The company advanced its Maniry Graphite Project in Madagascar and expanded operations in India and Europe.
- A placement led by Atlas Strategic Assets raised approximately A$2.3 million to strengthen Evion's cash position.
- Evion secured a A$1.5 million sales agreement for expandable graphite with a major US group.
- Ongoing engagement with European partners includes grant applications totaling over €1.2 million.
- The Maniry Project is recognized by the EU as a Strategic Project under the Critical Raw Materials Act.
- Evion ended the quarter with a cash balance of A$2.3 million.
- The company continues to focus on building a non-Chinese supply chain for critical minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$4 |
Proposed issue of securities - IVX
|
30 Jan 2026 6:15PM |
$0.092 |
$0.044 |
fallen by
52.17%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$4 |
Proposed issue of securities - IVX
|
30 Jan 2026 6:14PM |
$0.092 |
$0.044 |
fallen by
52.17%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$4 |
Major Shareholders Lead Invion $1.3M Capital Raise
|
30 Jan 2026 6:14PM |
$0.092 |
$0.044 |
fallen by
52.17%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion raised $1.3 million via a Convertible Note offering.
- Funding will accelerate clinical trials for cancer treatments.
- Prof Thian Chew and Ms. XiaoYi Wu acted as cornerstone investors.
- Tranche One raised $578k under ASX rule 7.1; Tranche Two requires shareholder approval.
- Funds support clinical trials, partner-funded studies, and working capital.
- Non-interest-bearing notes with a conversion floor of 9 cents.
- Expected milestones include clinical trial updates and ethics approvals.
- Prof Chew's investment in Tranche Two requires shareholder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sagalio Energy Limited (SAN) ORDINARY FULLY PAID |
Energy |
$2 |
Quarterly Activities Report
|
30 Jan 2026 6:13PM |
$0.012 |
$0.012 |
fallen by
0%
|
|
SAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Phase 2 drilling at Rosewood Titanium Discovery.
- Significant expansion of mineralized area exceeding 20 square kilometers.
- High-grade, shallow intersections confirming continuity of mineralization.
- Bulk sample metallurgical testing ongoing.
- Appointment of Mr. Rob Sennitt as Executive Director.
- Financial position includes $8.4 million in cash.
- Plans to increase stake in tenement EL 6715 to 70%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sagalio Energy Limited (SAN) ORDINARY FULLY PAID |
Energy |
$2 |
Quarterly Appendix 5B Cash Flow Report
|
30 Jan 2026 6:12PM |
$0.012 |
$0.012 |
fallen by
0%
|
|
SAN - Price-sensitive ASX Announcement
Full Release
Key Points
- The Quarterly Appendix 5B Cash Flow Report is for Sagalio Energy Limited.
- The report details cash flows for the quarter ended 30 June 2025.
- There was a net cash outflow from operating activities amounting to $350,000.
- Cash used in investing activities totaled $757,000, primarily for exploration and evaluation expenses.
- Net cash from financing activities was $213,000.
- The total cash and cash equivalents at the end of the quarter were $8,395,000.
- The company has no unused financing facilities available.
- Estimated quarters of funding available are 8.3.
- The report provides compliance statements according to Australian Accounting Standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cosmos Exploration Limited (C1X) ORDINARY FULLY PAID |
Materials |
$27 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 6:12PM |
$0.086 |
$0.110 |
risen by
27.91%
|
|
C1X - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarter ending 31 December 2025.
- Cash and cash equivalents reduced to $169,000.
- Negative cash flow from operating activities: $295,000.
- Negative cash flow from investing activities: $40,000.
- No net cash inflows from financing activities.
- Active tenements in Quebec and Nunavut, Canada.
- 100% interest in its claims.
- Cash runway of 0.57 quarters.
- Seeking additional funding through financiers and shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BetaShares Western Asset Australian Bond Fund (Managed Fund) (BNDS) |
Financials |
$852 |
Final Distribution Announcement
|
30 Jan 2026 6:12PM |
$23.410 |
$23.310 |
fallen by
0.43%
|
|
| Jayride Group Limited (JAY) ORDINARY FULLY PAID |
Industrials |
$9 |
Dec25 Quarterly Activities Report and Appendix 4C
|
30 Jan 2026 6:11PM |
$0.006 |
$0.006 |
fallen by
0%
|
|
| Ainsworth Game Technology Limited (AGI) ORDINARY FULLY PAID |
Consumer Discretionary |
$515 |
Novomatic Offer - Final extension to 6 February 2026
|
30 Jan 2026 6:11PM |
$1.035 |
$1.530 |
risen by
47.83%
|
|
AGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Novomatic AG extends its takeover offer for Ainsworth Game Technology Limited.
- The offer will remain open until 6 February 2026.
- The bidder's statement was originally dated 3 September 2025.
- Formal notice of variation of the offer's terms was lodged with ASIC.
- Shareholders and relevant parties have been notified under the Corporations Act.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alexium International Group Limited (AJX) ORDINARY FULLY PAID |
Materials |
$22 |
Change of Director's Interest Notice - RL
|
30 Jan 2026 6:09PM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$218 |
Change of Director's Interest Notice - Norman Seckold
|
30 Jan 2026 6:08PM |
$0.170 |
$0.220 |
risen by
29.41%
|
|
| Alexium International Group Limited (AJX) ORDINARY FULLY PAID |
Materials |
$22 |
Change of Director's Interest Notice - PS
|
30 Jan 2026 6:08PM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
| Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$18 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 6:07PM |
$0.020 |
$0.014 |
fallen by
28.21%
|
|
HIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Preliminary Feasibility Study completed for Hawsons Iron Project.
- 2.3 billion tonnes of Ore Reserves declared.
- Target production of 257 million tonnes of magnetite concentrate over 26 years.
- Pre-tax IRR of 10.93% and NPV8 of A$1,360M.
- Total initial capital requirement of A$4.96B.
- Ending cash balance of A$524k as of December 31, 2025.
- Operational cash outflows were A$369k and investing outflows A$576k.
- Capital raising efforts underway.
- New board appointments to support project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Discovery Alaska Limited (DAF) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities & Cashflow Report - December 2025
|
30 Jan 2026 6:06PM |
$0.018 |
$0.014 |
fallen by
22.22%
|
|
DAF - Price-sensitive ASX Announcement
Full Release
Key Points
- Discovery Alaska Limited reported its quarterly activities and financials for December 2025.
- The company holds a 100% interest in the Chulitna Gold Project and an option for the Boulder Creek Gold-Silver Project.
- Exploration efforts focused on historically anomalous areas in the Boulder Creek Project.
- Cash reserves stood at approximately $0.1 million at the end of the quarter.
- The company incurred $29,000 in exploration and evaluation costs.
- Discovery Alaska is exploring funding options to sustain operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$86 |
Application for quotation of securities - PAR
|
30 Jan 2026 6:05PM |
$0.305 |
$0.150 |
fallen by
50.82%
|
|